Upgrade to SI Premium - Free Trial

Pre-Open Stock Movers 03/04: (INO) (UNH) (ANTM) Higher (CLDX) (OMI) (JWN) Lower (more...)

March 4, 2020 9:06 AM

Today's Pre-Open Stock Movers

Cardlytics (NASDAQ: CDLX) 27.8% LOWER; reported Q4 EPS of $0.18, $0.14 better than the analyst estimate of $0.04. Revenue for the quarter came in at $69.3 million versus the consensus estimate of $63.89 million. Cardlytics sees Q1 2020 revenue of $43.5-46.5 million vs $52.77 million expected.

Covetrus (NASDAQ: CVET) 14.4% HIGHER; reported Q4 EPS of ($0.33), $0.45 worse than the analyst estimate of $0.12. Revenue for the quarter came in at $1.01 billion versus the consensus estimate of $986.26 million. Covetrus sees FY2020 revenue of $4.025-4.125 billion, versus the consensus of $4.14 billion.

Inovio Pharma (NASDAQ: INO) 14% HIGHER; adds to today's 70% intra-day gains following vaccine update

DURECT Corp (NASDAQ: DRRX) 12.8% HIGHER; reported Q4 EPS of ($0.02), in-line with the analyst estimate of ($0.02). Revenue for the quarter came in at $10.7 million versus the consensus estimate of $10.91 million.

Vir Biotechnology, Inc. (Nasdaq: VIR) 11.2% HIGHER; Vir Biotechnology and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) today announced an expansion of their existing collaboration to include the development and commercialization of RNAi therapeutics targeting SARS-CoV-2, the virus that causes the disease COVID-19. Under the agreement, the companies will utilize Alnylams recent advances in lung delivery of novel conjugates of siRNA the molecules that mediate RNAi together with Virs infectious disease expertise and established capabilities, to bring forward one or more siRNAs to treat SARS-CoV-2 and potentially other coronaviruses as well. The collaboration will focus on development of siRNAs that Alnylam recently identified that target highly conserved regions of coronavirus RNAs.

UnitedHealth Group (NYSE: UNH) 10.6% HIGHER; Managed care stocks are indicated to open sharply higher as Joe Biden picks up momentum with a number of Super Tuesday wins.

Ambarella (NASDAQ: AMBA) 9.4% HIGHER; reported Q4 EPS of $0.14, $0.03 better than the analyst estimate of $0.11. Revenue for the quarter came in at $57.2 million versus the consensus estimate of $57.18 million.

Anthem (NYSE: ANTM) 9.2% HIGHER; Managed care stocks are indicated to open sharply higher as Joe Biden picks up momentum with a number of Super Tuesday wins.

Cigna Corp. (NYSE: CI) 9% HIGHER; Managed care stocks are indicated to open sharply higher as Joe Biden picks up momentum with a number of Super Tuesday wins.

Humana (NYSE: HUM) 9% HIGHER; Managed care stocks are indicated to open sharply higher as Joe Biden picks up momentum with a number of Super Tuesday wins.

Ownes & Minor (NYSE: OMI) 9% LOWER; reported Q4 EPS of $0.24, $0.01 better than the analyst estimate of $0.23. Revenue for the quarter came in at $2.19 billion versus the consensus estimate of $2.48 billion. Ownes & Minor sees FY2020 EPS of $0.50-$0.60, versus the consensus of $0.76.

Centene Corporation (NYSE: CNC) 8.3% HIGHER; Managed care stocks are indicated to open sharply higher as Joe Biden picks up momentum with a number of Super Tuesday wins.

Nordstrom (NYSE: JWN) 8% LOWER; reported Q4 EPS of $1.23, $0.24 worse than the analyst estimate of $1.47. Revenue for the quarter came in at $4.54 billion versus the consensus estimate of $4.56 billion. Nordstrom sees FY2020 EPS of $3.25-$3.50, versus the consensus of $3.49.

Yext, Inc. (NYSE: YEXT) 7.2% HIGHER; reported Q4 EPS of ($0.12), $0.02 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $81.38 million versus the consensus estimate of $80.16 million. Yext, Inc. sees Q1 2021 EPS of ($0.14)-($0.11), versus the consensus of ($0.10). Yext, Inc. sees Q1 2021 revenue of $85-87 million, versus the consensus of $86.55 million. Yext, Inc. sees FY2021 EPS of ($0.50)-($0.45), versus the consensus of ($0.43). Yext, Inc. sees FY2021 revenue of $378-382 million, versus the consensus of $380.67 million.

AeroVironment (NASDAQ: AVAV) 6.2% LOWER; reported Q3 EPS of ($0.01), $0.14 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $61.9 million versus the consensus estimate of $68.81 million. AeroVironment sees FY2020 EPS of $1.55-$1.75, versus the consensus of $1.64. AeroVironment sees FY2020 revenue of $350-370 million, versus the consensus of $359.4 million.

Hewlett Packard Enterprise (NYSE: HPE) 5.6% LOWER; reported Q1 EPS of $0.44, in-line with the analyst estimate of $0.44. Revenue for the quarter came in at $6.9 billion versus the consensus estimate of $7.24 billion. Hewlett Packard Enterprise sees FY2020 EPS of $1.78-$1.94, versus the consensus of $1.96.

CVS Health (NYSE: CVS) 5.6% HIGHER; Managed care stocks are indicated to open sharply higher as Joe Biden picks up momentum with a number of Super Tuesday wins.

Fox Factory Holding (NASDAQ: FOXF) 5.5% HIGHER; reported Q4 EPS of $0.65, $0.03 better than the analyst estimate of $0.62. Revenue for the quarter came in at $185.9 million versus the consensus estimate of $180.34 million. Fox Factory Holding sees Q1 2020 EPS of $0.55-$0.60, versus the consensus of $0.58. Fox Factory Holding sees Q1 2020 revenue of $182-190 million, versus the consensus of $180.31 million. Fox Factory Holding sees FY2020 EPS of $3.00-$3.10, versus the consensus of $2.97. Fox Factory Holding sees FY2020 revenue of $881-906 million, versus the consensus of $844.71 million.

Veeva Systems (NYSE: VEEV) 4.6% HIGHER; reported Q4 EPS of $0.54, $0.02 better than the analyst estimate of $0.52. Revenue for the quarter came in at $311.5 million versus the consensus estimate of $298.3 million. Veeva Systems sees Q1 2021 EPS of $0.59-$0.60, versus the consensus of $0.56. Veeva Systems sees Q1 2021 revenue of $327-328 million, versus the consensus of $315.25 million. Veeva Systems sees FY2021 EPS of $2.50-$2.51, versus the consensus of $2.51. Veeva Systems sees FY2021 revenue of $1.4-1.405 billion, versus the consensus of $1.38 billion.

Urban Outfitters (NASDAQ: URBN) 4.5% LOWER; reported Q4 EPS of $0.50, $0.13 worse than the analyst estimate of $0.63. Revenue for the quarter came in at $1.17 billion versus the consensus estimate of $1.17 billion.

Ross Stores (NASDAQ: ROST) 3.6% LOWER; reported Q4 EPS of $1.28, $0.03 better than the analyst estimate of $1.25. Revenue for the quarter came in at $4.4 billion versus the consensus estimate of $4.36 billion. Ross Stores sees Q1 2020 EPS of $1.16-$1.21, versus the consensus of $1.25. Ross Stores sees FY2020 EPS of $4.67-$4.88, versus the consensus of $5.01.

Vectrus, Inc. (NYSE: VEC) 3.5% LOWER; reported Q4 EPS of $0.93, $0.02 better than the analyst estimate of $0.91. Revenue for the quarter came in at $365.3 million versus the consensus estimate of $365.66 million. Vectrus, Inc. sees FY2020 EPS of $3.48-$3.81, versus the consensus of $3.77. Vectrus, Inc. sees FY2020 revenue of $1.475-1.525 billion, versus the consensus of $1.52 billion.

Chipotle Mexican Grill (NYSE: CMG) 3.3% HIGHER; Wells Fargo upgraded from Equal Weight to Overweight with a price target of $1,000.00.

Centene Corporation (NYSE: CNC) 2.8% LOWER; announced today its updated 2020 financial guidance, incorporating the effect of the closing of the WellCare acquisition on January 23, 2020. Total revenues are expected to be $104.8 billion to $105.6 billion, and diluted earnings per share are expected to be $3.00 to $3.14. Adjusted diluted earnings per share for 2020 are expected to be $4.56 to $4.76.

Home Depot (NYSE: HD) 2% HIGHER; Nomura/Instinet analyst Michael Baker upgraded from Neutral to Buy with a price target of $251.00.

Categories

Special Reports

Next Articles